Translational Medicine Research Institute of CAS and SMMU founded in Shanghai

The inaugural meeting of the founding of the "Translational Medicine Research Institute of the Chinese Academy of Sciences (CAS) and the Second Military Medical University (SMMU)" was held on April 26, 2012. This is the first research entity set up by the CAS outside in cooperation with other organization in life science field. The founding of the research institute is a useful attempt to explore a development road of military and civilian integration and an initiative action to comply with the development trend of medicine science and technology.

The management body of the newly founded Translational Medicine Research Institute, adopting the president-in-charge system under the leadership of the board of directors, is located in the SMMU. It has three research centers and a key technical platform which will focus on the translational medicine researches in diseases with high incidence and high hazard among Chinese people such as malignant tumors, cardiovascular disease, transplantation immunity and digestion and urinary systems in a bid to provide new strategies and new ways for the prevention and treatment of diseases to push the prevention and control process of major diseases in China, promote the formation of a contingent of world-level academic leaders in translational medicine field, and upgrade translational medicine research level to provide scientific and technological support for the formulation of national health policy and overall improvement in people's health standard.